Allspring Global Investments Holdings LLC Has $29.88 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Allspring Global Investments Holdings LLC cut its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 223,931 shares of the medical research company's stock after selling 5,450 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.08% of Agilent Technologies worth $29,879,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in A. AMF Tjanstepension AB acquired a new position in Agilent Technologies during the third quarter worth $2,726,000. Creative Planning boosted its stake in shares of Agilent Technologies by 5.9% during the 3rd quarter. Creative Planning now owns 44,910 shares of the medical research company's stock worth $6,668,000 after buying an additional 2,498 shares during the last quarter. Global Retirement Partners LLC grew its holdings in shares of Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company's stock valued at $382,000 after acquiring an additional 79 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Agilent Technologies by 2.0% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,737 shares of the medical research company's stock valued at $5,603,000 after acquiring an additional 757 shares during the last quarter. Finally, V Square Quantitative Management LLC raised its holdings in Agilent Technologies by 5.7% during the third quarter. V Square Quantitative Management LLC now owns 6,387 shares of the medical research company's stock worth $948,000 after acquiring an additional 343 shares in the last quarter.

Analyst Ratings Changes

A number of brokerages have recently commented on A. Bank of America decreased their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Barclays upgraded Agilent Technologies from an "underweight" rating to an "equal weight" rating and lifted their price target for the stock from $135.00 to $145.00 in a report on Monday, February 10th. Wells Fargo & Company lowered their price target on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a research report on Monday, December 9th. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the company a "buy" rating in a research report on Thursday, December 19th. Finally, StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $144.38.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Agilent Technologies Stock Performance

Shares of A stock traded up $2.01 on Wednesday, hitting $137.21. The company's stock had a trading volume of 1,253,543 shares, compared to its average volume of 1,655,580. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09. The stock's 50 day moving average is $141.21 and its 200-day moving average is $139.31. The company has a market capitalization of $39.15 billion, a PE ratio of 31.04, a PEG ratio of 3.65 and a beta of 1.07.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business's revenue for the quarter was up .8% on a year-over-year basis. During the same period last year, the firm earned $1.38 earnings per share. Equities research analysts expect that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.